AI
Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Valted Seq Raises $10.5 Million In Seed Funding Round
11/02/21, 11:00 AM
Location
gaithersburg
Money raised
$10.5 million
Round Type
seed
Valted Seq, a biotechnology company focused on the genetic elucidation of neurodegenerative disease pathways to accelerate development of new therapeutics and diagnostics, today announced the completion of a seed fundraising round totaling $10.5 million. Dongkoo Bio&Pharma Co. Ltd. led the financing round which also included new investor OV Principal Investments, LLC and several independent investors
Company Info
Location
gaithersburg, maryland, united states
Additional Info
Valted Seq is focused on the discovery of neurodegenerative disease pathways to accelerate development of new therapeutics and diagnostics, including companion diagnostics which play a critical role in enabling advanced therapeutics. Using its HiF-Seq platform, the company has created the world’s largest repository of transcriptomic data from high-quality, clinically characterized brain tissues of patients with neurodegenerative diseases including Alzheimer’s and Parkinson’s. Valted Seq was co-founded in 2019 by Ted Dawson, Valina Dawson and D&D Pharmatech. For more information, please visit www.valtedseq.com.
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.